Progression-free survival is often calculated for the treatment of diseases that are slow-growing and difficult to cure, like low-grade lymphomas. This term is also used whensalvage treatmentsare offered in situations where the intention is not a cure but the control of disease. In the case of...
PROGRESSION-free survivalNOMOGRAPHY (Mathematics)SQUAMOUS cell carcinomaSURVIVAL rateSCOTSDEATH certificatesOVERALL survivalDesign Retrospective cohort study.Cohort selection OroGrams is a nomogram designed to better predict survival patterns in patients with oropharyngeal squamous cell carcinoma (OPSCC) by ...
Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival. J Invest Dermatol. 2018;138(3):679–87. Article CAS PubMed Google Scholar Kozuma Y, Takada K, Toyokawa G, Kohashi K, ...
Median progression-free survival (mPFS) is the amount of time it takes for the cancer to progress in the body or for death to occur in at least 50% of people in the study. In the review of results in May 2021, the mPFS for Enhertu had not been reached, meaning that more than 50...
To determine whether the post-external beam radiotherapy (RT) prostate-specific antigen nadir (nPSA) improves our ability to predict freedom from PSA failure, progression-free survival (PFS), and overall survival. Controversy regarding the importance of nPSA after external beam RT as a prognostic in...
The primary endpoint of the study was radiographic progression-free survival (the length of time during and after the treatment that cancer does not progress or worsen), which was not reached in the Xtandi plus ADT group, compared with 19.45 months with placebo and ADT. This reduced t...
lowered testosterone. The study mainly measured how well the drug worked by looking at how long people lived without their cancer getting worse, known as progression-free survival, and how long people lived in general, known as overall survival. The results from the TITAN study were as follows...
In order to measure the effectiveness of interventions claiming to improve adherence in diabetes, valid measurement of adherence is necessary. Any measurem... H Hearnshaw,A Lindenmeyer - 《Diabetic Medicine》 被引量: 72发表: 2010年 Progression-Free Survival: What Does It Mean for Psychological ...
[10]. Interestingly, a positive association has been described with the development of immune-related adverse events after the use of ICI therapy and progression-free survival (PFS), overall survival (OS), and objective response rate (ORR). However, for higher toxicities, this association was ...
Clin Cancer Res 10(11): 3650 – 3657 Flaherty KT, Rosen MA, Heitjan DF, Gallagher ML, Schwartz B, Schnall MD, O'Dwyer PJ (2008) Pilot study of DCE-MRI to predict progression- free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther 7(4): 496 – 501 British ...